Thursday, March 10, 2011
Stem Cell Directors Conclude Cardiovascular Session
The briefing on cardiovascular disease for directors of the California stem cell agency has concluded. The governing board is expected to convene shortly to deal with other matters, ranging from selection of a new chair to a $125,000 program to send patient advocates to the World Stem Cell Stem Summit in Pasadena.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment